bioRxiv / medRxiv
open access
CC BY-NC-ND 4.0
WITHDRAWN: Escherichia coli Microcin B17 as a chassis for the development of novel antimicrobial peptides.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The rise and future of peptide-based antimicrobials.#988764
- Discovery of New Amphipathic Helix Antibacterial Peptides with Proteomic Analysis using LC-HRMS and Virtual Screening#194512
- Benchmark antimicrobial and non-antimicrobial peptide datasets#353642
- Integrative computational-experimental discovery and translation of antifungal peptides for multidrug-resistant fungi.#368054
- Machine learning-driven discovery of antimicrobial peptides against Pseudomonas aeruginosa.#354747
Record · ID 10061
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive